Staphylococcus aureus: Visiting a strain of clinical importance;Staphylococcus aureus: Visitando uma cepa de importância hospitalar

Jornal Brasileiro de Patologia e Medicina Laboratorial

Volumn 43, Issue 6, 2007, Pages 413-423

  Dos Santos, André Luis ^a   Santos, Dilvani Oliveira ^b   De Freitas, Cícero Carlos ^b   Ferreira, Bruno Leal Alves ^a   Afonso, Ilídio F ^c   Rodrigues, Carlos Rangel ^c   Castro, Helena C ^a,b  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b IB/CEG/UFF

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

HeteroVISA; Microbial resistance; MRSA; S. aureus; VISA; VRSA

Indexed keywords

EID: 41549093312     PISSN: 16762444     EISSN: 16784774     Source Type: Journal    
DOI: 10.1590/S1676-24442007000600005     Document Type: Review

References (46)

1. ANDRIOLO, A. Guias de medicina ambulatorial e hospitalar. São Paulo: Editora Manole, 2005.
2. BERNARD, L. et al. Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant S. aureus strains. J Microbiol Meth, v. 57, p. 231-9, 2004.
3. BRAUNWALD, E. et al. Harrison Medicina Interna. 15. ed. Rio de Janeiro: Mcgraw-Hill Interamericana do Brasil, 2002.
4. BADDOUR, M. M.; ABUELKHEIR, M. A.; FATANI, A. J. Trends in antibiotic susceptibility patterns and epidemiology of MRSA isolates from several hospitals in Riyadh, Saudi Arabia. Ann Clin Microbiol Antimicrob, v. 5, n.30, 2006.
5. BRATU, S. et al. A population-based study examining the emergence of community-associated methicillin-resistant S. aureus USA300 in New York City. Ann Clin Microbiol Antimicrob, v. 5, n. 29, 2006.
6. BALABAN, N. et al. Auto inducer of virulence as a target for vaccine and therapy against S. aureus. Science, v. 280, p. 438-40, 1998.
7. BANNERMAN, T. L. Staphylococcus, Micrococcus and other catalase-positive cocci that aerobically. In: MURRAY, P. R. et al. (eds.). Man Clin Microbiol. 8. ed. Washington, DC: ASM Press, 2003. vol. 1, p. 384-404.
8. CARVALHO, C. et al. Monitoramento microbiológico seqüencial da secreção traqueal em pacientes intubados internados em unidade de terapia intensiva pediátrica. J Pediatr, v. 81, n. 1, p. 29-33, 2005.
9. CASSETTARI, V. C.; STRABELLI, T.; MEDEIROS, E. A. S. Staphylococcus aureus bacteremia: what is the impact of oxacillin resistance on mortality ? Braz J Infect Dis, v. 9, n. l, p. 70-6, 2005.
10. CDC. Interim guidelines for prevention and control of stafilococcal infection associated with reduced susceptibility to vancomycin. MMWR, v. 46, n. 26, p. 626-7, 1997.
11. CAVALCANTI, S. et al. Prevalence of Staphylococcus aureus introduced into intensive care units of a university hospital. Braz J Infect Dis, v. 9, n. 1, p. 56-63, 2005.
12. CENTERS FOR DISEASE CONTROL AND PREVENTION. BRIEF REPORT. Vancomycin-resistant S. aureus - New York, 2004. MMWR Morb Mortal Wkly Rep, v. 53, p. 322-3, 2004.
13. DAVIS, J. S. Management of bone and joint infections due to Staphylococcus aureus. Int Med J, v. 35, p. 79S-96S, 2005.
14. FREITAS C. C.; FONSECA, A. Aspectos genéticosbioquímicos da resistência bacteriana aos antibióticos. In: ZANON, U.; NEVES, J. Infecções hospitalares: prevenção, diagnóstico e tratamento. Rio de Janeiro: MEDSI, 1987. p. 207-49.
15. FOSTER, T. J.; HOOK, M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol, v. 6, p. 484-8, 1998.
16. GOSBELL, I. B. Diagnosis and management of catheter-related bloodstream infections due to Staphylococcus aureus. Intern Med J, v. 35, p. 45S-62S, 2005.
17. IWATSUKI, K. et al. Staphylococcal cutaneous infections: invasion, evasion and aggression. J Dermatol Sci, v. 42, p. 203-14, 2006.
18. KONEMAN, E. et al. Diagnóstico microbiológico. 5 ed. Rio de Janeiro: Guanabara Koogan, 2001. cap. 11, parte 1.
19. LIMA, D. C. et al. Snake venom: any clue for antibiotics and cam? Evid Based Complement Alternat Med, v. 2, n. 1, p. 39-47, 2005.
20. LUTZ, L. et al. Clinical failure of vancomycin treatment of Staphylococcus aureus infection in a tertiary care hospital in southern Brazil. Braz J Infect Dis,v. 7, n. 3, p. 224-8, 2003.
21. LOPES, H. V. CA-MRSA: um novo problema para o infectologista. Rev Panam Infectol, v. 7, n. 3, p. 34-6, 2005.
22. LARCOMBE, L. et al. Rapid emergence of methicillin-resistant Staphylococcus aureus (MRSA) among children and adolescents in northern Manitoba, 2003-2006. Can Commun Dis Rep, v. 33, n. 2, p. 9-14, 2007.
23. LOWY, F. D. Medical progress: Staphylococcus aureus infections. N Eng J Med, v. 339, p. 520-32, 1998.
24. MAMISUKA, E. Projeto de resistência microbiana em serviços de saúde, Staphylococcus. ANVISA, 2005. Disponível em: 〈http//:www. anvisa. gov. br〉.
25. MACHADO, A. et al. Cost-effectiveness of linezolid versus vancomycin in mechanical ventilation-associated nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Braz J Infect Dis, v. 9, n. 3, p. 191-200, 2005.
26. MICHELIM, L. et al. Fatores de patogenicidade e resistência a antimicrobianos em Staphylococcus epidermidis associados a infecções nosocomiais em unidades de terapia intensiva. Braz J Microbiol, v. 36, n. 1, p. 17-23, 2005.
27. MURCKO, M. A. Recent advances in ligand design methods. Rev Comp Chem, v. 11, p. 1-66, 1997.
28. NOVICK, R. P. Pathogenicity factors and their regulation. In: FISCHETTI, V. A. et al. (eds.). Washington DC: ASM Press, 2000. p. 392-407.
29. OLIVEIRA, G. A. et al. Avaliação da tolerância à vancomicina em 365 cepas hospitalares de Staphylococcus aureus resistentes à oxacilina. J Bras Patol, v. 37, n. 4, p. 239-46, 2001.
30. RIBEIRO, J. et al. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) among patients visiting the emergency room at a tertiary hospital in Brazil. Braz J Infect Dis, v. 9, n. 1, p. 52-5, 2005.
31. ROBERT, S.; CHAMBERS, S. Diagnosis and management of Staphylococcus aureus infections of the skin and soft tissue. Intern Med J, v. 35, p. 97S-105S, 2005.
32. RODRIGUES, C. A.; VESGA, O. Staphylococcus aureus resistente à vancomicina. Biomédica, v. 25, p. 575-87, 2005.
33. REAGAN, D. R. et al. Elimination of coincident S. aureus nasal and hand carriage with intranasal application of mupiricin calcium ointment. Ann Intern Med, v. 114, p. 101-6, 1991.
34. SCHECHTER, M.; MARANGONI, D. V. Doenças infecciosas: conduta, diagnóstico e terapêutica. 2. ed. Rio de Janeiro: Guanabara Koogan, 1998.
35. SRINIVASAN, A.; DICK, J. D.; PERL, T. M. Vancomycine resistence in staphylococci. Clin Microbiol Rev, v. 15, n. 3, p. 430-8, 2002.
36. TAVARES, W. Manual de antibióticos e quimioterápicos antiinfecciosos. Rio de Janeiro: Editora Atheneu, 1999.
37. TAVARES, W. Bactérias Gram-positivas problemas: resistência do estafilococo, do enterococo e do pneumococo aos antimicrobianos. Rev Soc Bras Med Trop, v. 33, p. 281-301, 2000.
38. TAVARES, W. Manual de antibióticos e quimioterápicos antiinfecciosos. Rio de Janeiro: Editora Atheneu, 2002. caps. 1 e 5.
39. TENOVER, F. C.; MCDONALD, L. C. Vancomycin-resistent staphylococci and enterococci: epidemiology and control. Curr Op Infect Dis, n. 18, p. 300-5, 2005.
40. TRABULSI, L. R.; ALTHERTHUM, F. Microbiologia. Staphylococcus aureus. São Paulo: Atheneu, 2005. cap. 20, p. 175-82.
41. TIWARI, H. K.; SEN, M. R. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect Dis, v. 6, n. 156, 2006.
42. VELÁQUEZ, J. et al. Vigilancia de la resistencia de Staphylococcus aureus a la oxacilina-vancomicina y patrones de corresistencia. Rev Per Soc Med Intern, v. 15, n. 4, 2002.
43. VELÁZQUEZ-MEZA, M. E. Staphylococcus aureus methicillin-resistant: emergence and dissemination. Salud Pública de México, v. 47, p. 381-7, 2005.
44. WALSH, T. R.; ROBIN, A. H. The prevalence and mechanisms of vancomycin resistence in Staphylococcus aureus. Ann Rev Microbiol, v. 56, p. 657-75, 2005.
45. WENZEL, R. P.; EDMOND, M. B. Vancomycin-resistant Staphylococcus aureus: infection control considerations. Clin Infect Dis, v. 27, n. 2, p. 245-51, 1998.
46. MUTO, C. A. et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol, v. 24, p. 362-86, 2003.